These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31125907)

  • 1. Hedgehog signaling inhibitors in solid and hematological cancers.
    Cortes JE; Gutzmer R; Kieran MW; Solomon JA
    Cancer Treat Rev; 2019 Jun; 76():41-50. PubMed ID: 31125907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.
    Katoh M
    Clin Sci (Lond); 2019 Apr; 133(8):953-970. PubMed ID: 31036756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma.
    Lear JT; Morris LM; Ness DB; Lewis LD
    Expert Rev Clin Pharmacol; 2023; 16(12):1211-1220. PubMed ID: 37975712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer.
    Xie H; Paradise BD; Ma WW; Fernandez-Zapico ME
    Cells; 2019 Apr; 8(5):. PubMed ID: 31035664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer.
    Brechbiel J; Miller-Moslin K; Adjei AA
    Cancer Treat Rev; 2014 Jul; 40(6):750-9. PubMed ID: 24613036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma.
    Doan HQ; Chen L; Nawas Z; Lee HH; Silapunt S; Migden M
    Oncotarget; 2021 Sep; 12(20):2089-2100. PubMed ID: 34611482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Delivery of Hedgehog Inhibitors: Current Status and Perspectives.
    Pedersen KK; Høyer-Hansen MH; Litman T; Hædersdal M; Olesen UH
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas.
    Wahid M; Jawed A; Mandal RK; Dar SA; Khan S; Akhter N; Haque S
    Crit Rev Oncol Hematol; 2016 Feb; 98():235-41. PubMed ID: 26614022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment.
    Terao T; Minami Y
    Cells; 2019 Apr; 8(4):. PubMed ID: 30987263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer.
    Yun JI; Kim HR; Park H; Kim SK; Lee J
    Arch Pharm Res; 2012 Aug; 35(8):1317-33. PubMed ID: 22941475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway.
    Sekulic A; Mangold AR; Northfelt DW; LoRusso PM
    Curr Opin Oncol; 2013 May; 25(3):218-23. PubMed ID: 23493193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma.
    Proctor AE; Thompson LA; O'Bryant CL
    Ann Pharmacother; 2014 Jan; 48(1):99-106. PubMed ID: 24259609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma.
    Cirrone F; Harris CS
    Clin Ther; 2012 Oct; 34(10):2039-50. PubMed ID: 23036338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the Hedgehog pathway in lung cancer.
    Dimou A; Bamias A; Gogas H; Syrigos K
    Lung Cancer; 2019 Jul; 133():56-61. PubMed ID: 31200829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of Hedgehog inhibitors in acute myeloid leukemia and establishment of valid biomarkers].
    Minami Y
    Rinsho Ketsueki; 2019; 60(7):843-846. PubMed ID: 31391375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting hedgehog in hematologic malignancy.
    Irvine DA; Copland M
    Blood; 2012 Mar; 119(10):2196-204. PubMed ID: 22223823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog inhibitors: a patent review (2013 - present).
    Xin M
    Expert Opin Ther Pat; 2015 May; 25(5):549-65. PubMed ID: 25726713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive monitoring of basal cell carcinomas treated with systemic hedgehog inhibitors: pseudocysts as a sign of tumor regression.
    Maier T; Kulichova D; Ruzicka T; Berking C
    J Am Acad Dermatol; 2014 Oct; 71(4):725-30. PubMed ID: 24928708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.
    Queiroz KC; Spek CA; Peppelenbosch MP
    Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging from their burrow: Hedgehog pathway inhibitors for cancer.
    Gan GN; Jimeno A
    Expert Opin Investig Drugs; 2016 Oct; 25(10):1153-66. PubMed ID: 27459882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.